This pipeline uses various statistical tests to identify mRNAs whose log2 expression levels correlated to selected clinical features.
Testing the association between 18552 genes and 7 clinical features across 507 samples, statistically thresholded by P value < 0.05 and Q value < 0.3, 4 clinical features related to at least one genes.
-
634 genes correlated to 'AGE'.
-
DIO2|1734 , PTCH1|5727 , FAM107A|11170 , S100A1|6271 , DUSP9|1852 , ...
-
4973 genes correlated to 'HISTOLOGICAL.TYPE'.
-
KIAA1324|57535 , L1CAM|3897 , PPAP2C|8612 , FOXA2|3170 , IL20RA|53832 , ...
-
180 genes correlated to 'RADIATIONS.RADIATION.REGIMENINDICATION'.
-
RPL23AP82|284942 , RPL23AP7|118433 , LOC341056|341056 , UBE2MP1|606551 , EDARADD|128178 , ...
-
303 genes correlated to 'RACE'.
-
SORD|6652 , LRRC37A2|474170 , ACTB|60 , LOC90784|90784 , DHRS4L1|728635 , ...
-
No genes correlated to 'Time to Death', 'COMPLETENESS.OF.RESECTION', and 'ETHNICITY'.
Complete statistical result table is provided in Supplement Table 1
Clinical feature | Statistical test | Significant genes | Associated with | Associated with | ||
---|---|---|---|---|---|---|
Time to Death | Cox regression test | N=0 | ||||
AGE | Spearman correlation test | N=634 | older | N=365 | younger | N=269 |
HISTOLOGICAL TYPE | Kruskal-Wallis test | N=4973 | ||||
RADIATIONS RADIATION REGIMENINDICATION | Wilcoxon test | N=180 | yes | N=180 | no | N=0 |
COMPLETENESS OF RESECTION | Kruskal-Wallis test | N=0 | ||||
RACE | Kruskal-Wallis test | N=303 | ||||
ETHNICITY | Wilcoxon test | N=0 |
Time to Death | Duration (Months) | 0-191.8 (median=22.8) |
censored | N = 445 | |
death | N = 60 | |
Significant markers | N = 0 |
AGE | Mean (SD) | 63.82 (11) |
Significant markers | N = 634 | |
pos. correlated | 365 | |
neg. correlated | 269 |
SpearmanCorr | corrP | Q | |
---|---|---|---|
DIO2|1734 | -0.3583 | 9.029e-17 | 1.68e-12 |
PTCH1|5727 | -0.3357 | 8.552e-15 | 1.59e-10 |
FAM107A|11170 | 0.3345 | 1.073e-14 | 1.99e-10 |
S100A1|6271 | 0.3269 | 4.583e-14 | 8.5e-10 |
DUSP9|1852 | 0.3294 | 2.64e-13 | 4.9e-09 |
MGAT4A|11320 | 0.3137 | 5.123e-13 | 9.5e-09 |
NR2F6|2063 | 0.3102 | 9.51e-13 | 1.76e-08 |
DLC1|10395 | -0.3099 | 9.972e-13 | 1.85e-08 |
FBXL16|146330 | 0.3084 | 1.312e-12 | 2.43e-08 |
HIF3A|64344 | 0.3106 | 1.34e-12 | 2.49e-08 |
HISTOLOGICAL.TYPE | Labels | N |
ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | 382 | |
MIXED SEROUS AND ENDOMETRIOID | 20 | |
SEROUS ENDOMETRIAL ADENOCARCINOMA | 105 | |
Significant markers | N = 4973 |
ANOVA_P | Q | |
---|---|---|
KIAA1324|57535 | 1.891e-40 | 3.51e-36 |
L1CAM|3897 | 4.539e-39 | 8.42e-35 |
PPAP2C|8612 | 5.93e-38 | 1.1e-33 |
FOXA2|3170 | 1.085e-37 | 2.01e-33 |
IL20RA|53832 | 8.331e-37 | 1.55e-32 |
HIF3A|64344 | 1.396e-36 | 2.59e-32 |
SLC6A12|6539 | 1.948e-36 | 3.61e-32 |
SPDEF|25803 | 6.618e-36 | 1.23e-31 |
TFF3|7033 | 1.262e-35 | 2.34e-31 |
CDKN1A|1026 | 1.829e-35 | 3.39e-31 |
180 genes related to 'RADIATIONS.RADIATION.REGIMENINDICATION'.
RADIATIONS.RADIATION.REGIMENINDICATION | Labels | N |
NO | 137 | |
YES | 370 | |
Significant markers | N = 180 | |
Higher in YES | 180 | |
Higher in NO | 0 |
W(pos if higher in 'YES') | wilcoxontestP | Q | AUC | |
---|---|---|---|---|
RPL23AP82|284942 | 14413 | 8.497e-14 | 1.58e-09 | 0.7157 |
RPL23AP7|118433 | 14625 | 2.523e-13 | 4.68e-09 | 0.7115 |
LOC341056|341056 | 15270 | 6.098e-12 | 1.13e-07 | 0.6988 |
UBE2MP1|606551 | 15787.5 | 6.842e-11 | 1.27e-06 | 0.6885 |
EDARADD|128178 | 15842 | 8.764e-11 | 1.63e-06 | 0.6875 |
POTEE|445582 | 15594 | 1.242e-10 | 2.3e-06 | 0.6864 |
UBE2NL|389898 | 15592.5 | 1.879e-10 | 3.49e-06 | 0.685 |
LOC100130932|100130932 | 16064 | 2.368e-10 | 4.39e-06 | 0.6831 |
PGAM4|441531 | 16145 | 3.385e-10 | 6.28e-06 | 0.6815 |
TPI1P3|728402 | 14894 | 3.434e-10 | 6.37e-06 | 0.6839 |
COMPLETENESS.OF.RESECTION | Labels | N |
R0 | 351 | |
R1 | 22 | |
R2 | 17 | |
RX | 30 | |
Significant markers | N = 0 |
RACE | Labels | N |
AMERICAN INDIAN OR ALASKA NATIVE | 4 | |
ASIAN | 19 | |
BLACK OR AFRICAN AMERICAN | 90 | |
NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER | 9 | |
WHITE | 359 | |
Significant markers | N = 303 |
ANOVA_P | Q | |
---|---|---|
SORD|6652 | 7.398e-15 | 1.37e-10 |
LRRC37A2|474170 | 5.173e-14 | 9.6e-10 |
ACTB|60 | 1.136e-13 | 2.11e-09 |
LOC90784|90784 | 4.18e-13 | 7.75e-09 |
DHRS4L1|728635 | 2.163e-12 | 4.01e-08 |
PPIL3|53938 | 3.66e-12 | 6.79e-08 |
ANXA2P3|305 | 6.493e-12 | 1.2e-07 |
EIF5AL1|143244 | 2.341e-11 | 4.34e-07 |
LOC644165|644165 | 1.001e-10 | 1.86e-06 |
CTAGE4|100128553 | 1.114e-10 | 2.07e-06 |
-
Expresson data file = UCEC-TP.uncv2.mRNAseq_RSEM_normalized_log2.txt
-
Clinical data file = UCEC-TP.merged_data.txt
-
Number of patients = 507
-
Number of genes = 18552
-
Number of clinical features = 7
For survival clinical features, Wald's test in univariate Cox regression analysis with proportional hazards model (Andersen and Gill 1982) was used to estimate the P values using the 'coxph' function in R. Kaplan-Meier survival curves were plot using the four quartile subgroups of patients based on expression levels
For continuous numerical clinical features, Spearman's rank correlation coefficients (Spearman 1904) and two-tailed P values were estimated using 'cor.test' function in R
For multi-class clinical features (ordinal or nominal), one-way analysis of variance (Howell 2002) was applied to compare the log2-expression levels between different clinical classes using 'anova' function in R
For two-class clinical features, two-tailed Student's t test with unequal variance (Lehmann and Romano 2005) was applied to compare the log2-expression levels between the two clinical classes using 't.test' function in R
For multiple hypothesis correction, Q value is the False Discovery Rate (FDR) analogue of the P value (Benjamini and Hochberg 1995), defined as the minimum FDR at which the test may be called significant. We used the 'Benjamini and Hochberg' method of 'p.adjust' function in R to convert P values into Q values.
In addition to the links below, the full results of the analysis summarized in this report can also be downloaded programmatically using firehose_get, or interactively from either the Broad GDAC website or TCGA Data Coordination Center Portal.